津药药业(600488.SH)：盐酸甲氧氯普胺注射液获得药品注册证书

Core Viewpoint - The company, Tianyao Pharmaceutical (600488.SH), announced that its subsidiary, Hubei Tianyao Pharmaceutical Co., Ltd., has received the drug registration certificate for Metoclopramide Hydrochloride Injection from the National Medical Products Administration [1] Group 1 - The approved drug, Metoclopramide Hydrochloride Injection, is primarily used as an antiemetic for various conditions including chemotherapy, radiotherapy, surgery, and brain injuries [1] - The medication is indicated for symptomatic treatment of nausea and vomiting associated with acute gastroenteritis, biliary and pancreatic disorders, and uremia [1] - It also aids in facilitating duodenal intubation prior to diagnostic procedures and helps reduce nausea and vomiting during gastrointestinal barium X-ray examinations [1]